Document is current
Any future updates will be listed below
-
Authors
Barata, Catarina http://orcid.org/0000-0002-2852-7723
Rotemberg, Veronica
Codella, Noel C. F.
Tschandl, Philipp http://orcid.org/0000-0003-0391-7810
Rinner, Christoph http://orcid.org/0000-0002-3847-5664
Akay, Bengu Nisa http://orcid.org/0000-0002-4896-1666
Apalla, Zoe
Argenziano, Giuseppe http://orcid.org/0000-0003-1413-8214
Halpern, Allan
Lallas, Aimilios
Longo, Caterina
Malvehy, Josep
Puig, Susana http://orcid.org/0000-0003-1337-9745
Rosendahl, Cliff http://orcid.org/0000-0001-5182-2969
Soyer, H. Peter
Zalaudek, Iris
Kittler, Harald http://orcid.org/0000-0002-0051-8016
- License Information
-
More Information
Article History
Received: 31 August 2022
Accepted: 28 June 2023
First Online: 27 July 2023
Competing interests
: The authors declare the following competing interests: P.T. has received fees from Silverchair, speaker honoraria from FotoFinder, Lilly and Novartis, and an unrestricted one-year postdoc grant from MetaOptima Technology Inc. N.C. is a Microsoft employee and owns diverse investments across technology and healthcare companies. A.H. is a consultant to Canfield Scientific Inc. and advisory board member of Scibase AB. H.P.S. is a shareholder of MoleMap NZ Limited and e-derm consult GmbH and undertakes regular teledermatological reporting for both companies. H.P.S. is also a medical consultant for Canfield Scientific Inc., MoleMap Australia Pty Ltd, Blaze Bioscience Inc. and a medical adviser for First Derm. V.R. is a medical adviser for Inhabit Brands, Inc. H.K. received nonfinancial support from Derma Medical Systems, Fotofinder and Heine, and speaker fees from Fotofinder. The remaining authors declare no competing interests.
